Sandbox jo: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 33: | Line 33: | ||
:*Useful in monitoring or predicting treatment response | :*Useful in monitoring or predicting treatment response | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | ''' | | style="padding: 5px 5px; background: #DCDCDC;" | '''HBeAg''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Negative in an estimated 85% of patients | |||
*Associated with detectable anti-HBe | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''HBV DNA Polymerase''' | | style="padding: 5px 5px; background: #DCDCDC;" | '''HBV DNA Polymerase''' |
Revision as of 20:58, 6 August 2014
Diagnostic Markers | Significance |
---|---|
Anti-HDV IgG antibody |
|
Anti-HDV IgM antibody |
|
HDV RNA |
Qualitative
Quantitative
|
HBsAg |
Qualitative
Quantitative
|
HBeAg |
|
HBV DNA Polymerase | |
HBV DNA Polymerase |